整个表观基因组的关联研究,元分析和帕金森病全血多分数分析
Ingeborg Haugesag Lie1,2, Manuela M X Tan1, Maren Stolp Andersen1
1Department of Neurology, Oslo University Hospital, Oslo, Norway.
Annals of clinical and translational neurology
|February 5, 2025
概括
DNA甲基化分析显示,它有可能成为帕金森病 (PD) 风险的生物标志物. 结合遗传风险和甲基化模式的联合模型准确地将PD患者与对照患者区分开来,这表明其在精准医学中的实用性.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 改变的DNA甲基化越来越多地与帕金森病 (PD) 有关.
- 这些甲基化变化的可复制性和生物标志物潜力在很大程度上仍未被探索.
- 了解表观遗传修饰对于推动PD研究至关重要.
研究的目的:
- 为了研究DNA甲基化失调在帕金森病中的作用.
- 评估基于甲基化的PD分析的生物标志物潜力.
- 确定与PD相关的特定DNA甲基化模式.
主要方法:
- 在280名PD患者和279名对照的全血中进行了一项全表观基因组关联研究 (EWAS).
- 进行了EWAS元分析,包括3068名参与者的数据 (包括帕金森氏症进展标记计划 (PPMI)).
- 开发并测试了基于甲基化的得分,结合多基因风险,以评估与PD状态的关联.
主要成果:
- 证实了SLC7A11过甲基化,并确定了PD中LPIN1附近的新型差异甲基化CpG.
- 综合遗传风险,甲基化估计,吸烟和白细胞比例的联合多分数模型在奥斯陆队列中达到0.82的AUC,在PPMI中达到0.65.
- 该模型有效地将PD患者与对照参与者区分开来.
结论:
- 基因组甲基化分析表明,在神经退行性疾病中捕获多面性疾病风险的显著潜力.
- 基于甲基化的生物标志物可能对神经学中的精准医学方法有价值.
- 特定CpG的有限可重现性表明,未来的研究应该考虑疾病阶段和环境因素.
更多相关视频
08:09Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
7.0K
12:49Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
7.4K
相关概念视频
01:11Genome-wide Association Studies-GWAS
12.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.4K
01:15Parkinson's Disease: Overview
447
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
447
01:37Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K